Press ESC to close

Opti-GuideOpti-Guide

EssilorLuxottica Delivers Solid Third-Quarter Results Across All Regions

EssilorLuxottica announced today that consolidated revenue for the third quarter of 2026 reached Euro 7,486 million, representing a year-on-year increase of 7.2% at constant exchange rates1 compared to the third quarter of 2025 (+9.0% at current exchange rates).

Executive Leadership Commentary and Growth Highlights

Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO at EssilorLuxottica commented: “Quarter after quarter, our Company continues to demonstrate the strength of its unique model. In the third quarter, we delivered 9% revenue growth, with all regions contributing and Asia-Pacific standing out with double-digit growth. Our eyecare, eyewear and medtech activities remained a powerful engine of growth, up over 6% in both the quarter and the first nine months of the year, while wearables’ revenue increased 20%, confirming the strong momentum behind this emerging category we continue to lead.

Our myopia management portfolio continued its exceptional trajectory, growing 24% in both the quarter and year to date. As we head into the holiday season, new AI glasses launches and the rollout of Nuance Audio Plus are further strengthening our wearable portfolio, offering people new ways to engage with and navigate the world around them. We were also proud to see Stellest recognized by TIME among the Best Inventions of the Year, highlighting the impact our innovation has in addressing one of the most pressing health challenges of our time and improving the lives of millions of children worldwide.

Above all, these achievements reflect the passion, talent and commitment of our people around the world. Their ability to strengthen the business that defines us today while accelerating our expansion across science, clinical care and surgery sets EssilorLuxottica apart and gives us great confidence in the future.”

 

* * *

Unless otherwise specified, the commentary in the following pages is based on revenue performance at constant exchange rates1 versus 2025

 

Opti-News Newsletter
line opti
Receive the latest Canadian eyecare news, weekly.
Trusted by +8,000 subscribers.